Abbott Laboratories Q3 Earnings Report Shows $1.15 Earnings Per Share

Abbott Laboratories reported earnings per share (EPS) of $1.15 for the third quarter, exceeding analysts' expectations. Revenue for the quarter reached $10.2 billion, reflecting a year-over-year increase of 5%. The company has a price-to-earnings (P/E) ratio of 22.4. This performance may influence market sentiment regarding healthcare stocks, particularly in the context of ongoing economic recovery.

Informational only, not financial advice. Content is AI-generated and may contain errors. How this works.